Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Francesca Carobolante"'
Autor:
Michele Malagola, MD, Nicola Polverelli, MD, Massimo Martino, MD, Francesca Patriarca, MD, Benedetto Bruno, MD, Luisa Giaccone, MD, Giovanni Grillo, MD, Stefania Bramanti, MD, Paolo Bernasconi, MD, Marco De Gobbi, MD, Annalisa Natale, MD, Elisabetta Terruzzi, MD, Attilio Olivieri, MD, Patrizia Chiusolo, MD, Angelo Michele Carella, MD, Marco Casini, MD, Enrico Maffini, MD, Chiara Nozzoli, MD, Patrizio Mazza, MD, Simona Bassi, Francesco Onida, MD, Adriana Vacca, MD, Sadia Falcioni, MD, Mario Luppi, MD, Anna Paola Iori, MD, Vincenzo Pavone, MD, Cristina Skert, MD, Paola Carluccio, MD, Carlo Borghero, MD, Anna Proia, MD, Carmine Selleri, MD, Vicky Rubini, MD, Nicoletta Sacchi, MD, Elena Oldani, MD, Francesca Bonifazi, MD, Fabio Ciceri, MD, Domenico Russo, MD, Simona Bernardi, Mirko Farina, Maria Fiore, Maria Teresa Lupo Stanghellini, Renato Fanin, Danilo Giuseppe Faraci, Luca Castagna, Anna Amelia Colombo, Paolo Nicoli, Stella Santarone, Ilaria Scortechini, Elisabetta Metafuni, Emanuela Merla, Irene Cavattoni, Ilaria Cutini, Annamaria Mazzone, Giorgia Saporiti, Filippo Antonio Canale, Eugenia Piras, Piero Galieni, Giulia Debbia, Ursula La Rocca, Anna Mele, Francesca Carobolante, Francesca Elice, Fulvia Fanelli
Publikováno v:
Transplantation Direct, Vol 9, Iss 3, p e1451 (2023)
Background. The conditioning regimens with different alkylators at different doses can influence the outcome of allogeneic stem cell transplantation (SCT), but conclusive data are missing. Methods. With the aim to analyze real-life allogeneic SCTs pe
Externí odkaz:
https://doaj.org/article/f52ad82b2231458eb6e334ecb921fb0f
Publikováno v:
Therapeutic Advances in Hematology, Vol 11 (2020)
The outstanding therapeutic progress achieved with modern pediatric regimens in childhood acute lymphoblastic leukemia (ALL) led efforts to explore whether a similar treatment approach could be equally effective and safe in older patients, starting i
Externí odkaz:
https://doaj.org/article/3f7faf5095c84b2b8b3eaadc4fdaf5e3
Autor:
Gianluca GESSONI, Giulia DE FUSCO, Francesca POLESE, Michela PIVETTA, Ileana VACCARA, Filomena AQUINO, Giorgio FARINA, Piero MARSON, Silvia ZANIBELLATO, Francesca CAROBOLANTE, Giulia PERALI, Renato BASSAN, Cristina SKERT
Publikováno v:
La Rivista Italiana della Medicina di Laboratorio. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a139f58dc01c8fea8c14b133ba3700fc
https://doi.org/10.23736/s1825-859x.21.00119-5
https://doi.org/10.23736/s1825-859x.21.00119-5
Autor:
Piero Galieni, Mario Luppi, Giovanni Grillo, Paola Carluccio, Ursula La Rocca, Paolo Nicoli, Luisa Giaccone, Chiara Nozzoli, Simona Bassi, Patrizio Mazza, Attilio Olivieri, Renato Fanin, Filippo Antonio Canale, Eugenia Piras, Benedetto Bruno, Sonia Mammoliti, Anna Proia, Stella Santarone, Massimo Martino, Adriana Vacca, Fabio Ciceri, Patrizia Chiusolo, Giulia Debbia, Ilaria Cutini, Anna Colombo, Marco Casini, Ilaria Scortechini, Carmine Selleri, Carlo Borghero, Cristina Skert, Francesca Elice, Maria Teresa Lupo Stanghellini, Mario Arpinati, Domenico Russo, Vicky Rubini, Anna Paola Iori, Emanuela Merla, Elena Oldani, Giorgia Saporiti, Anna Mele, Francesca Patriarca, Fulvia Fanelli, Nicola Polverelli, Francesca Bonifazi, Sadia Falcioni, Vincenzo Pavone, Francesca Carobolante, Francesco Onida, Luca Castagna, Elisabetta Metafuni, Danilo Giuseppe Faraci, Stefania Bramanti, Elisabetta Terruzzi, Paolo Bernasconi, Annamaria Mazzone, Annalisa Natale, Irene Cavattoni, Marco De Gobbi, Michele Malagola, Nicoletta Sacchi, Angelo Michele Carella
Publikováno v:
Blood. 138:1786-1786
The upper age-limit for patients with hematological malignancies eligible for allo-SCT progressed to 70-75 years. As a consequence, an increase of older patients submitted to allo-SCT has been observed worldwide and in Italy as well. This registry-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0a98014b055a6b843f836541e52faf6
https://doi.org/10.1182/blood-2021-145970
https://doi.org/10.1182/blood-2021-145970
Autor:
Piera Viero, Francesca Gianni, Rosaria Sancetta, Francesca Carobolante, Paola Stefanoni, Renato Bassan, Tamara Intermesoli, Alessandro Rambaldi, Elena Maino, Manuela Tosi, Annamaria Scattolin, Orietta Spinelli
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:S2-S9
The study of minimal residual disease (MRD) in adult patients with acute lymphoblastic leukemia (ALL) allows a greater refinement of the individual risk classification and is the best support for risk-specific therapy with or without allogeneic hemat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5409badd54842c69f5f63af85433d6
https://doi.org/10.1016/j.clml.2017.02.019
https://doi.org/10.1016/j.clml.2017.02.019
Autor:
Massimo Dozzo, Piera Viero, Francesca Carobolante, Annamaria Scattolin, Elena Maino, Renato Bassan, Pietro Maria Donisi, Rosaria Sancetta
Publikováno v:
Adolescent Health, Medicine and Therapeutics
About one-half of all Burkitt lymphoma (BL) patients are younger than 40 years, and one-third belong to the adolescent and young adult (AYA) subset, defined by an age between 15 and 25–40 years, based on selection criteria used in different reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6598fe70b9befae76b569bc33ff6f2a1
https://doi.org/10.2147/ahmt.s94170
https://doi.org/10.2147/ahmt.s94170
Autor:
Matteo Leoncin, Giulia Perali, Piera Viero, Luca Frison, Manuela Tosi, Cristina Skert, Federico Lussana, Alessandro Rambaldi, Francesca Carobolante, Chiara Pavoni, Renato Bassan, Roberta Cavagna, Orietta Spinelli, Tamara Intermesoli
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2108, p 2108 (2021)
Cancers, Vol 13, Iss 2108, p 2108 (2021)
Simple Summary In acute lymphoblastic leukemia (ALL), once a complete remission is achieved following induction chemotherapy, the study of submicroscopic minimal residual disease (MRD) represents a highly sensitive tool to assess the efficacy of earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e490c7ac6f0af10e81a266acafa10e8
https://doi.org/10.3390/cancers13092108
https://doi.org/10.3390/cancers13092108
Autor:
Francesca Carobolante, Giulia Perrone, Silvia Buttignol, Annalisa Pezzi, Michele Baccarani, Emanuela Englaro, Beatrice Anna Zannetti, Cristina Nanni, Michele Cavo, Annamaria Brioli, Lucia Pantani, Stefano Fanti, Renato Fanin, Elena Zamagni, Carolina Terragna, Paola Tacchetti, Francesca Patriarca
We prospectively analyzed the prognostic relevance of positron emission tomography–computed tomography (PET/CT) at diagnosis, after thalidomide-dexamethasone (TD) induction therapy and double autotransplantation (ASCT) in 192 newly diagnosed multip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c8f9ad1d9b49f1fb8c76b8823c2964
http://hdl.handle.net/11585/110764
http://hdl.handle.net/11585/110764
Autor:
Paolo Corradini, Francesca Patriarca, Miriam Isola, H. Einsele, R Fanin, Alberto Bosi, Andrea Nozza, G. Stuhler, Fortunato Morabito, Benedetto Bruno, Chiara Nozzoli, Alessandra Sperotto, Moreno Festuccia, Francesco Spina, Marta Medeot, Francesca Carobolante, Chiara Cigana
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:e268
PO-331 Long Term Follow-Up of a Donor Versus no Donor Comparison in Multiple Myeloma Patients at First Relapse After Previous Autotransplant F. Patriarca, H. Einsele, F. Spina, B. Bruno, M. Isola, C. Cigana, A. Sperotto, F. Carobolante, C. Nozzoli, A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4e05ecb76ee5c6421ed46a2f2c19736
https://doi.org/10.1016/j.clml.2015.07.562
https://doi.org/10.1016/j.clml.2015.07.562
Autor:
Miriam Isola, Francesca Patriarca, Silvia Buttignol, Elena Zamagni, Renato Fanin, Vittorio Montefusco, Paolo Corradini, Benedetto Bruno, Emanuaela Englaro, Raffaella Stocchi, Cristina Nanni, Alessandra Sperotto, Onelio Geatti, Francesca Carobolante, Michele Cavo
Publikováno v:
Biology of Blood and Marrow Transplantation. (6):1068-1073
Positron emission tomography (PET) integrated with computed tomography (PET/CT) has been reported to be useful for screening myelomatous lesions at diagnosis in patients with multiple myeloma (MM) and for monitoring response to autologous stem cell t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17014e204a52a1addcbe7eef4c7420fe